Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kestra Med Technologies Ltd. SHS | 0 | 1,795,893 | +1,795,893 | $0 | $44.75M | 26.41% | +$44.75M |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | $38.41M | $28.73M | 16.95% | -$9.68M |
| Beta Bionics, Inc.(BBNX) | 0 | 1,988,287 | +1,988,287 | $0 | $24.34M | 14.36% | +$24.34M |
| Nuvation Bio Inc.CL A(NUVB) | 13,072,340 | 13,072,340 | 0 | $34.77M | $23.01M | 13.58% | -$11.77M |
| Replimune Group, Inc.(REPL) | 1,975,203 | 1,975,203 | 0 | $23.92M | $19.26M | 11.36% | -$4.66M |
| Upstream Bio, Inc.(UPB) | 2,036,293 | 2,036,293 | 0 | $33.48M | $12.46M | 7.35% | -$21.01M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,184,636 | 1,184,636 | 0 | $7.79M | $4.11M | 2.43% | -$3.68M |
| Alumis Inc. | 653,223 | 653,223 | 0 | $5.13M | $4.01M | 2.37% | -$1.12M |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | $3.69M | $2.88M | 1.70% | -$809.7K |
| enGene Holdings Inc. COM | 526,357 | 526,357 | 0 | $3.50M | $2.36M | 1.39% | -$1.14M |
| Immunic, Inc.(IMUX) | 1,788,160 | 1,788,160 | 0 | $1.79M | $1.95M | 1.15% | +$160.9K |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $1.38M | $1.42M | 0.84% | +$42.2K |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 321,502 | 321,502 | 0 | $271.1K | $192.9K | 0.11% | -$78.2K |
| Syros Pharmaceuticals | 251,270 | 0 | -251,270 | $57.8K | $0 | — | -$57.8K |